Compare Swedencare AB with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROCE of 3.19%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 9.42
3
Healthy long term growth as Net Sales has grown by an annual rate of 62.07% and Operating profit at 17.17%
4
With ROE of 1.02%, it has a attractive valuation with a 0.76 Price to Book Value
5
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
SEK 3,988 Million (Small Cap)
74.00
NA
497.53%
0.21
0.91%
0.60
Revenue and Profits:
Net Sales:
682 Million
(Quarterly Results - Dec 2025)
Net Profit:
16 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-37.14%
0%
-37.14%
6 Months
-29.78%
0%
-29.78%
1 Year
-38.25%
0%
-38.25%
2 Years
-64.87%
0%
-64.87%
3 Years
-1.13%
0%
-1.13%
4 Years
-78.32%
0%
-78.32%
5 Years
-71.03%
0%
-71.03%
Swedencare AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
62.07%
EBIT Growth (5y)
17.17%
EBIT to Interest (avg)
9.42
Debt to EBITDA (avg)
2.65
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.28
Tax Ratio
37.58%
Dividend Payout Ratio
80.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.19%
ROE (avg)
2.39%
Valuation key factors
Factor
Value
P/E Ratio
74
Industry P/E
Price to Book Value
0.76
EV to EBIT
38.71
EV to EBITDA
13.96
EV to Capital Employed
0.80
EV to Sales
2.62
PEG Ratio
NA
Dividend Yield
376.73%
ROCE (Latest)
2.08%
ROE (Latest)
1.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
682.30
661.30
3.18%
Operating Profit (PBDIT) excl Other Income
106.90
136.30
-21.57%
Interest
20.60
17.70
16.38%
Exceptional Items
0.00
0.00
Consolidate Net Profit
16.40
23.80
-31.09%
Operating Profit Margin (Excl OI)
38.40%
83.50%
-4.51%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 3.18% vs 5.44% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is -31.09% vs 283.08% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,683.10
2,530.20
6.04%
Operating Profit (PBDIT) excl Other Income
446.00
537.40
-17.01%
Interest
75.00
82.20
-8.76%
Exceptional Items
0.00
-1.70
100.00%
Consolidate Net Profit
55.50
98.90
-43.88%
Operating Profit Margin (Excl OI)
50.40%
87.50%
-3.71%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 6.04% vs 8.84% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -43.88% vs 68.77% in Dec 2024
About Swedencare AB 
Swedencare AB
Pharmaceuticals & Biotechnology
Swedencare publ AB is a Sweden-based company, which is mainly involved in the veterinary supplies industry. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores and pharmacies. It operates through four subsidiaries, namely SDC Distribution for Scandinavian countries, Buccosante located in France, Informpet in the United Kingdom and SwedencareUSA in the United States. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Powder, ProDen PlaqueOff Powder Cat and ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.
Company Coordinates 
Company Details
Medeon Science Park , MALMO None : 205 12
Registrar Details






